Director, Global Migraine Patient Strategy

Ipsen; Cambridge (MA); Hybrid; USD 191,000 - 275,000; Full time

Benefits offered by this job

401(k) with company contributions

Medical, dental, vision insurance

Life and disability insurance

Well-being allowance

Commuter benefits

Parental leave

Job summary

Ipsen seeks a Director to define and lead the global consumer strategy and market development for migraine with the Dysport brand. The role drives patient insights, activation and experience across markets, leveraging advanced analytics and AI-enabled approaches.

You will partner with Global Medical, Market Access, Insights & Analytics and external agencies, and contribute to scalable patient- and market-driven plans from concept to launch while working from our Cambridge, MA HQ on a hybrid

Qualifications

• 10+ years of progressive experience in pharma or related healthcare industries.
• Strong experience in patient/customer strategy, marketing or market development.
• Experience with patient journey mapping and segmentation.

Responsibilities

• Lead development of the global patient strategy for Dysport in migraine across chronic and episodic migraine.
• Develop deep understanding of patient needs, beliefs, motivations and barriers.
• Define patient segments and create global engagement and activation programs.
• Advance analytics, ML and AI-enabled approaches to inform strategy and market development.
• Collaborate with Global Medical, Market Access, Insights & Analytics, and external partners.

Skills

Global strategy

Market development

Advanced analytics

Cross‑functional leadership

Education

Bachelor's Degree

MS/MBA or equivalent

Job description

Ipsen seeks a Director to define and lead the global consumer strategy and market development for migraine with the Dysport brand. The role drives patient insights, activation and experience across markets, leveraging advanced analytics and AI-enabled approaches.

You will partner with Global Medical, Market Access, Insights & Analytics and external agencies, and contribute to scalable patient- and market-driven plans from concept to launch while working from our Cambridge, MA HQ on a hybrid